XML 41 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Company's Stockholders Equity (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 30, 2021
Jul. 31, 2021
May 01, 2021
Oct. 31, 2020
Aug. 01, 2020
May 02, 2020
Oct. 30, 2021
Oct. 31, 2020
Balance at beginning of period $ 675,695 $ 539,892 $ 464,754 $ 262,260 $ 279,101 $ 528,149 $ 464,754 $ 528,149
Net income (loss) 13,619 102,554 171,030 8,016 (46,781) (333,728) $ 287,203 (372,493)
Stock options exercised 2,709 12,811 16,089 3,103 19,530 1,454    
Stock options exercised (in shares) [1]             346,436  
Shares used for tax withholding (3,202) (178) (13,083) $ (2,911) (2,350) (7,383)    
Shares purchased as part of publicly announced programs $ (150,010)         (50,158)    
Vesting of restricted shares, net of forfeitures of restricted shares 577,000     637,000     666,000  
Stock based compensation $ 17,297 23,180 12,879 $ 13,406 12,693 17,352    
Equity component of convertible notes issuance, net of related taxes of $44.1 million           131,916    
Shares issued to redeem convertible notes $ 151,206              
Shares issued to redeem convertible notes, (in shares) 888,000           971,000  
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit $ 6,509 (5,083) 825 583 (1,982) (9,609) $ 2,251 (11,008)
Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes 2,984 2,519 2,159 2,119 2,049 1,108 7,662 5,276
Balance at end of period 716,807 675,695 $ 539,892 286,576 262,260 279,101 716,807 286,576
Accounting Standards Update [Extensible List]     Accounting Standards Update (ASU) 2020-06          
Cumulative-effect Adjustment                
Balance at beginning of period   (114,761)            
Balance at end of period     $ (114,761)          
Common Stock                
Balance at beginning of period $ 7 $ 7 $ 7 $ 7 $ 7 $ 7 $ 7 $ 7
Balance at beginning of period (in shares) 81,041,969 80,897,050 80,661,453 80,414,151 80,084,171 79,882,506 80,661,453 79,882,506
Stock options exercised (in shares) 25,479 139,274 181,683 67,306 324,500 180,950    
Vesting of restricted shares, net of forfeitures of restricted shares 24,437 5,645 53,914 22,982 5,480 20,715    
Shares issued to redeem convertible notes, (in shares) 513,991              
Balance at end of period $ 7 $ 7 $ 7 $ 7 $ 7 $ 7 $ 7 $ 7
Balance at end of period (in shares) 81,605,876 81,041,969 80,897,050 80,504,439 80,414,151 80,084,171 81,605,876 80,504,439
Additional Paid-in Capital                
Balance at beginning of period $ 1,742,874 $ 1,706,883 $ 1,809,831 $ 1,770,091 $ 1,737,868 $ 1,587,146 $ 1,809,831 $ 1,587,146
Stock options exercised 2,709 12,811 16,089 3,103 19,530 1,454    
Stock based compensation 17,297 23,180 12,879 13,406 12,693 17,352    
Equity component of convertible notes issuance, net of related taxes of $44.1 million           131,916    
Shares issued to redeem convertible notes 151,206              
Balance at end of period 1,914,086 1,742,874 1,706,883 1,786,600 1,770,091 1,737,868 1,914,086 1,786,600
Additional Paid-in Capital | Cumulative-effect Adjustment                
Balance at beginning of period   (131,916)            
Balance at end of period     (131,916)          
Accumulated Earnings (Deficit)                
Balance at beginning of period 279,037 176,483 (11,702) (175,712) (128,931) 204,797 (11,702) 204,797
Net income (loss) 13,619 102,554 171,030 8,016 (46,781) (333,728)    
Balance at end of period 292,656 279,037 176,483 (167,696) (175,712) (128,931) 292,656 (167,696)
Accumulated Earnings (Deficit) | Cumulative-effect Adjustment                
Balance at beginning of period   17,155            
Balance at end of period     17,155          
Accumulated Other Comprehensive Loss                
Balance at beginning of period (22,595) (20,031) (23,015) (27,394) (27,461) (18,960) (23,015) (18,960)
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit 6,509 (5,083) 825 583 (1,982) (9,609)    
Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes 2,984 2,519 2,159 2,119 2,049 1,108    
Balance at end of period (13,102) (22,595) (20,031) (24,692) (27,394) (27,461) (13,102) (24,692)
Treasury Stock                
Balance at beginning of period $ (1,323,628) $ (1,323,450) $ (1,310,367) $ (1,304,732) $ (1,302,382) $ (1,244,841) $ (1,310,367) $ (1,244,841)
Balance at beginning of period (in shares) (14,317,493) (14,316,890) (14,275,122) (14,250,578) (14,237,470) (13,952,534) (14,275,122) (13,952,534)
Shares used for tax withholding $ (3,202) $ (178) $ (13,083) $ (2,911) $ (2,350) $ (7,383)    
Shares used for tax withholding (in shares) (10,898) (603) (41,768) (13,709) (13,108) (41,363)    
Shares purchased as part of publicly announced programs $ (150,010)         $ (50,158)    
Shares purchased as part of publicly announced programs, (in shares) (512,363)         (243,573)    
Balance at end of period $ (1,476,840) $ (1,323,628) $ (1,323,450) $ (1,307,643) $ (1,304,732) $ (1,302,382) $ (1,476,840) $ (1,307,643)
Balance at end of period (in shares) (14,840,754) (14,317,493) (14,316,890) (14,264,287) (14,250,578) (14,237,470) (14,840,754) (14,264,287)
[1] Options exercised during the nine month period ended October 30, 2021 had a total intrinsic value of $75.0 million.